Olivier Lafont - Concepedia

Author

Olivier Lafont

Université de Rouen Normandie

Also Known As

O LaFont, O Lafont, O. LAFONT, O. Lafont, O. Lafont,, OLIVIER LAFONT, Olivier LaFont, Olivier Lafont, С. В. Реушева

340

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Université de Rouen Normandie Centre National de la Recherche Scientifique Laboratoire de Chimie Organique Institut für Pharmakologie und Toxikologie der Bundeswehr Institut National des Sciences Appliquées Rouen Normandie

About

Olivier Lafont is an author at Université de Rouen Normandie specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	418
2	Biochemistry	10	10	260
3	Natural Sciences	7	7	195
4	Engineering	5	5	147
5	Biomedical Engineering	1	1	50

Olivier Lafont

Publications

749

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects Christian Lacroix, Thuthuy Hoang, J. Nouveau, European Journal of Clinical Pharmacology Healthy SubjectsPharmacological StudyPharmacologyPharmacotherapyMedicine	1989	75
Synthesis of 2-substituted β-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon Nicolas Masurier, François Estour, Marie‐Thérèse Froment, European Journal of Medicinal Chemistry Pharmaceutical ChemistryDerivativesCyclodextrin Production2-Substituted β-Cyclodextrin DerivativesHydrolytic Activity	2005	51
Primidone-loaded poly-ε-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles Vincent Ferranti, H. Marchais, Christiane Chabenat, International Journal of Pharmaceutics Polymer ChemistryEngineeringPharmaceutical NanotechnologyMicro-encapsulationDrug Delivery Systems	1999	50
Detoxification of nerve agents by a substituted β-cyclodextrin: Application of a modified biological assay Timo Wille, Oliver Tenberken, Georg Reiter, Toxicology Substituted β-CyclodextrinPharmaceutical ScienceBiochemistryMedicineCyclodextrin Production	2009	42
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: Evaluation of the detoxification using a half-quantitative enzymatic assay Raman Kumar Kalakuntla, Timo Wille, Romain Le Provost, Toxicology Letters Medicinal Chemistryβ-Cyclodextrin DerivativesBiochemistryMedicineNatural Sciences	2012	40
Handbook of Drug Screening Olivier Lafont European Journal of Medicinal Chemistry PharmacologyDrug TestingDrug TestDrug MonitoringDrug Screening	2002	39
Applied Electrospray Mass Spectrometry Olivier Lafont European Journal of Medicinal Chemistry Analytical InstrumentationNatural SciencesSpectroscopyMass SpectrometryProtein Mass Spectrometry	2002	38
Synthesis of variously 9,9-dialkylated octahydropyrimido [3,4-a]-s-triazines with potential antifungal activity Amar Ghaib, Sabine Ménager, Philippe Vérité, Il Farmaco Antifungal AgentEngineeringOrganic ChemistryPotential Antifungal ActivityPharmacology	2002	36
Interaction between allopurinol and pyrazinamide Christian Lacroix, C. Guyonnaud, M Chaou, European Respiratory Journal Uric Acid SynthesisAntiparasitic AgentPharmacotherapyNephrologyPharmaceutical Chemistry	1988	33
In vitro detoxification of cyclosarin (GF) by modified cyclodextrins Susanne Müller, Marianne Koller, Romain Le Provost, Toxicology Letters PharmacologyMedicinal ChemistryCyclodextrin ProductionVitro Detoxification	2010	31

Page 1